Tao Li

机构：Xinjiang Medical University, Henan University of Traditional Chinese Medicine, Anhui Medical University, Chinese Academy of Medical Sciences & Peking Union Medical College, Peking Union Medical College Hospital, First Affiliated Hospital of Xinjiang Medical University, Sichuan Cancer Hospital, People's Hospital of Xinjiang Uygur Autonomous Region, Ningxia Medical University, Ningxia Medical University General Hospital, Jilin Agricultural University, Zigong First People's Hospital, Qilu Hospital of Shandong University · ORCID：0000-0003-4854-4579

发表论文 32 篇 · 总被引 386 次 · h-index 8

代表论文

• Perioperative camrelizumab plus rivoceranib versus surgery alone in patients with resectable hepatocellular carcinoma at intermediate or high risk of recurrence (CARES-009): a randomised phase 2/3 trial (2025 · The Lancet · 被引 51)
• Neutral oligosaccharides from ginseng (Panax ginseng) residues vs. neutral ginseng polysaccharides: A comparative study of structure elucidation and biological activity (2024 · Food Chemistry · 被引 31)
• Dual-ferroptosis induction-based microneedle patches for enhanced chemodynamic/photothermal combination therapy against triple-negative breast cancer (2025 · Acta Pharmaceutica Sinica B · 被引 17)
• A novel DNA methylation signature associated with lymph node metastasis status in early gastric cancer (2022 · Clinical Epigenetics · 被引 17)
• Establishment of a prognostic model for gastric cancer patients who underwent radical gastrectomy using machine learning: a two-center study (2024 · Frontiers in Oncology · 被引 16)
• Diabetes mellitus promoted lymph node metastasis in gastric cancer: a 15–year single-institution experience (2021 · Chinese Medical Journal · 被引 9)